Jaundice Nursing Diagnosis and Nursing Care Plans

Jaundice is a clinical condition characterized by yellowing of the skin, sclera, and mucous membranes due to elevated bilirubin levels in the blood, typically exceeding 2.5–3 mg/dL in adults.

As nurses, we encounter jaundice in various settings—from neonatal units managing physiologic hyperbilirubinemia to medical-surgical floors caring for adults with liver disease or biliary obstruction.

Understanding jaundice is essential for nursing students preparing for the NCLEX and for practicing nurses at the bedside. Jaundice is not a diagnosis itself but rather a clinical sign indicating underlying pathology in bilirubin metabolism, liver function, or bile excretion.

The condition requires prompt nursing assessment, careful monitoring for complications, and targeted interventions to address both the visible symptoms and the root causes.

This guide provides comprehensive, evidence-based information on jaundice nursing diagnosis, including detailed assessment priorities, nursing interventions with rationales, and five example nursing care plans that reflect real clinical scenarios. Whether you’re studying for exams or caring for patients with hepatobiliary disorders, hemolytic conditions, or neonatal hyperbilirubinemia, this resource will strengthen your clinical judgment and care planning skills.

Definition and Overview

Jaundice (also called icterus) occurs when bilirubin accumulates in the blood and tissues, causing a yellow-green discoloration most visible in the skin and sclera. Bilirubin is a yellow pigment produced during the normal breakdown of red blood cells. Under normal conditions, the liver processes and excretes bilirubin through bile, but when this system is disrupted, bilirubin levels rise.

Jaundice becomes clinically visible when serum bilirubin reaches approximately 2.5–3 mg/dL in adults (normal range: 0.3–1.2 mg/dL). In newborns, physiologic jaundice commonly appears at 2–4 days of life as their immature liver systems adapt, but pathologic jaundice requires immediate intervention.

The condition can indicate serious underlying disorders, including hepatocellular injury (hepatitis, cirrhosis), biliary obstruction (gallstones, pancreatic cancer), or accelerated red blood cell breakdown (hemolytic anemia, transfusion reactions). Nurses play a critical role in early detection, ongoing monitoring, and patient education to prevent complications such as hepatic encephalopathy, kernicterus in neonates, or progression of liver failure.

Pathophysiology: Understanding Bilirubin Metabolism

To provide effective nursing care, we must understand how jaundice develops. Bilirubin metabolism occurs in three phases, and disruption at any point can cause jaundice.

Prehepatic Phase (Bilirubin Production):
When red blood cells reach the end of their 120-day lifespan, they are broken down in the spleen, liver, and bone marrow. Hemoglobin is converted to heme, which is then metabolized to unconjugated (indirect) bilirubin. This unconjugated bilirubin is lipid-soluble, binds to albumin in the bloodstream, and cannot be excreted by the kidneys.

Conditions causing excessive red blood cell breakdown—such as hemolytic anemia, sickle cell crisis, or transfusion reactions—produce more bilirubin than the liver can process, resulting in unconjugated hyperbilirubinemia.

Hepatic Phase (Bilirubin Conjugation):
Unconjugated bilirubin travels to the liver, where hepatocytes take it up and conjugate it with glucuronic acid via the enzyme UDP-glucuronosyltransferase. This creates conjugated (direct) bilirubin, which is water-soluble and can be excreted in bile.

Liver diseases such as hepatitis, cirrhosis, or drug-induced hepatotoxicity impair this conjugation process. In neonates, immature enzyme systems cause temporary inability to conjugate bilirubin efficiently, leading to physiologic jaundice.

Posthepatic Phase (Bilirubin Excretion):
Conjugated bilirubin is secreted into bile and flows through the biliary system into the intestines. Intestinal bacteria convert it to urobilinogen, which is either excreted in feces (giving stool its brown color) or reabsorbed and excreted by the kidneys (giving urine its yellow color).

Obstruction anywhere in the biliary tree—from gallstones, strictures, tumors, or cholangitis—prevents bile flow (cholestasis). This causes conjugated bilirubin to back up into the bloodstream, producing cholestatic jaundice with characteristic dark urine and pale, clay-colored stools.

Clinical Classification:

• Prehepatic jaundice: Increased RBC destruction; elevated unconjugated bilirubin
• Hepatic jaundice: Liver cell dysfunction; mixed bilirubin elevation
• Posthepatic (cholestatic) jaundice: Bile duct obstruction; elevated conjugated bilirubin

Causes and Related Factors

Jaundice can result from diverse underlying conditions affecting bilirubin production, metabolism, or excretion. Common etiologies include:

Hepatocellular Disease (Liver Dysfunction):

• Viral hepatitis (A, B, C, D, E)
• Alcoholic hepatitis or cirrhosis
• Drug-induced liver injury (acetaminophen toxicity, antibiotics, statins)
• Autoimmune hepatitis
• Primary biliary cholangitis
• Hepatocellular carcinoma
• Wilson’s disease
• Alpha-1 antitrypsin deficiency

Biliary Tract Obstruction (Cholestatic):

• Choledocholithiasis (gallstones in common bile duct)
• Cholangitis (bile duct infection)
• Pancreatic head cancer or cholangiocarcinoma
• Primary sclerosing cholangitis
• Biliary strictures or surgical injury
• Acute pancreatitis with biliary compression

Hemolytic Disorders (Prehepatic):

• Hemolytic anemia (autoimmune, hereditary spherocytosis)
• Sickle cell disease or crisis
• Glucose-6-phosphate dehydrogenase (G6PD) deficiency
• Transfusion reactions
• Mechanical heart valve hemolysis
• Malaria

Neonatal Causes:

• Physiologic jaundice (immature liver conjugation)
• Breastfeeding jaundice (insufficient intake)
• Breast milk jaundice (substances in breast milk)
• ABO or Rh incompatibility
• Cephalohematoma or birth trauma with increased RBC breakdown
• Biliary atresia
• Congenital infections (TORCH)

Other Contributing Factors:

• Sepsis or systemic infection
• Total parenteral nutrition (TPN)
• Heart failure with hepatic congestion
• Gilbert’s syndrome or Crigler-Najjar syndrome (genetic bilirubin conjugation disorders)

Signs and Symptoms (As Evidenced By)

Nurses assess for both subjective complaints and objective findings when evaluating jaundice. Clinical presentation varies based on the underlying cause and severity.

Subjective Data (Patient Reports):

• Generalized fatigue or weakness
• Abdominal pain or discomfort (especially right upper quadrant)
• Intense itching (pruritus), often worse at night
• Dark-colored urine (tea or cola-colored)
• Pale or clay-colored stools
• Loss of appetite or early satiety
• Nausea or vomiting
• Changes in mental clarity or confusion (hepatic encephalopathy)
• Recent exposure to hepatitis or jaundiced individuals
• History of alcohol use, medications, or herbal supplements

Objective Data (Nurse Observes and Measures):

• Visible jaundice: Yellow discoloration of skin, sclera, and mucous membranes (best assessed in natural light; progresses from head to trunk to extremities)
• Hepatomegaly: Enlarged, palpable liver with tenderness
• Splenomegaly: Enlarged spleen (in hemolytic conditions or portal hypertension)
• Ascites: Fluid accumulation in the abdomen (late-stage liver disease)
• Spider angiomata and palmar erythema: Signs of chronic liver disease
• Bruising or petechiae: Impaired clotting factor production
• Asterixis: Flapping tremor indicating hepatic encephalopathy
• Fever: May indicate infection (cholangitis, hepatitis)
• Cachexia or muscle wasting: Chronic malnutrition or malignancy

Laboratory Findings:

• Elevated total bilirubin (>1.2 mg/dL in adults)
• Elevated direct (conjugated) bilirubin in cholestatic jaundice
• Elevated indirect (unconjugated) bilirubin in hemolytic or hepatocellular jaundice
• Abnormal liver function tests: ALT, AST (hepatocellular injury); elevated alkaline phosphatase and GGT (cholestasis)
• Prolonged prothrombin time (PT/INR) indicating impaired liver synthetic function
• Low albumin in chronic liver disease
• Elevated ammonia in hepatic encephalopathy

Imaging and Diagnostic Findings:

• Abdominal ultrasound: Dilated bile ducts, gallstones, liver masses, or ascites
• CT scan or MRI: Detailed visualization of hepatobiliary structures and pancreas
• ERCP or MRCP: Identification of biliary obstruction or strictures

Expected Outcomes and Goals

When planning care for patients with jaundice, nurses establish measurable, patient-centered outcomes that align with NOC (Nursing Outcomes Classification) standards. Expected outcomes include:

• Skin integrity maintained: Patient will demonstrate a reduction in yellow discoloration of skin and sclera within 3–5 days, with bilirubin levels decreasing toward the normal range.
• Symptom relief: Patient will report decreased pruritus intensity from a self-rated score of 7/10 to 3/10 or less within 48 hours of implementing comfort interventions.
• Adequate nutrition maintained: Patient will consume at least 75% of meals and maintain stable body weight (±2 lbs) throughout hospitalization.
• Hydration status maintained: Patient will demonstrate balanced fluid intake and output (within 200 mL), with urine output ≥30 mL/hour and normal skin turgor.
• Complication prevention: Patient will remain free from signs of hepatic encephalopathy (oriented to person, place, time) and bleeding complications throughout care.
• Knowledge demonstration: Patient will verbalize understanding of the causes of jaundice, the treatment plan, dietary modifications, and signs/symptoms requiring immediate medical attention before discharge.
• Adherence to treatment: Patient will comply with prescribed phototherapy (neonates), medication regimen, dietary restrictions, and follow-up laboratory testing.
• Safe home transition: Patient/family will demonstrate ability to monitor jaundice at home, identify warning signs, and state when to contact the healthcare provider.

Nursing Assessment

A comprehensive nursing assessment establishes the foundation for effective care planning. Nurses must prioritize assessments based on patient acuity and the underlying cause of jaundice.

Priority Assessments and Red Flags

1. Assess jaundice severity and progression.
Examine skin, sclera, and oral mucosa in natural light for yellow discoloration. In newborns, jaundice progresses in a cephalocaudal pattern (head to feet), and progression below the umbilicus suggests bilirubin >12–15 mg/dL. Blanch the skin over bony prominences to better visualize underlying yellow tones.

Clinical tip: Jaundice appearing within the first 24 hours of life in neonates is always pathological and requires immediate intervention. In adults, rapidly progressing jaundice or jaundice with altered mental status constitutes an emergency.

2. Monitor vital signs and assess for infection.
Measure temperature, heart rate, blood pressure, and respiratory rate every 4–8 hours depending on acuity. Fever >101°F (38.3°C) may indicate cholangitis (biliary infection), hepatitis, or sepsis. Tachycardia and hypotension can signal sepsis or gastrointestinal bleeding.

Red flag: Fever with right upper quadrant pain and jaundice (Charcot’s triad) suggests acute cholangitis requiring urgent intervention.

3. Perform a comprehensive abdominal assessment.
Inspect for distension, visible venous patterns (caput medusae), or surgical scars. Auscultate bowel sounds. Palpate gently for hepatomegaly (liver edge >2 cm below right costal margin), tenderness, masses, or splenomegaly. Percuss for ascites using the shifting dullness technique.

Red flag: A firm, nodular liver suggests cirrhosis or malignancy; acute right upper quadrant tenderness with Murphy’s sign indicates cholecystitis.

4. Assess neurological status for hepatic encephalopathy.
Evaluate level of consciousness, orientation to person/place/time, speech clarity, and coordination. Test for asterixis (flapping tremor) by having the patient extend arms and dorsiflex wrists. Document any confusion, disorientation, lethargy, or personality changes.

Red flag: Altered mental status, asterixis, or confusion in a patient with liver disease indicates hepatic encephalopathy and requires immediate medical intervention and ammonia level testing.

5. Evaluate pruritus intensity and skin integrity.
Ask patients to rate itching on a 0–10 scale and identify when it’s worst (often nighttime in cholestatic jaundice). Inspect skin for excoriations, scratch marks, or breakdown. Assess fingernails for length and cleanliness to prevent infection from scratching.

Pruritus results from bile salt accumulation in the skin and can be severe enough to disrupt sleep and quality of life. Document any interventions previously tried at home.

6. Assess nutritional status and hydration.
Evaluate appetite, food preferences, meal tolerance, and recent weight changes. Review 24-hour dietary recall. Measure weight daily at the same time. Monitor intake and output, noting imbalances. Assess mucous membranes, skin turgor, and capillary refill for dehydration.

Jaundice often accompanies nausea, early satiety, and altered taste, leading to poor oral intake and malnutrition. Albumin levels <3.5 g/dL indicate protein malnutrition, common in chronic liver disease.

7. Monitor urine and stool characteristics.
Observe and document urine color (dark, tea-colored urine indicates conjugated bilirubinuria in cholestatic jaundice) and stool color (pale, clay-colored stools suggest biliary obstruction preventing bilirubin from reaching the intestines). In neonates, adequate stooling and urination indicate effective feeding and bilirubin elimination.

8. Review medication and substance use history.
Obtain a complete list of prescription medications, over-the-counter drugs, herbal supplements, and alcohol intake. Identify hepatotoxic medications such as acetaminophen, antibiotics, antifungals, statins, or herbal products that may contribute to liver injury.

9. Assess for bleeding risk.
Inspect for easy bruising, petechiae, bleeding gums, hematomas, or blood in stool/vomit. The liver produces clotting factors; hepatic dysfunction prolongs PT/INR and increases bleeding risk. Check recent laboratory values for thrombocytopenia or coagulopathy.

10. Evaluate psychosocial and cultural factors.
Assess the patient’s understanding of their condition, coping mechanisms, support systems, and cultural beliefs about illness. Jaundice can be visible and cause embarrassment or social isolation. Address fears about prognosis, especially if malignancy is suspected. In neonates, assess parental anxiety and bonding, as phototherapy can interfere with parent-infant interaction.

Nursing Interventions with Rationales

The following nursing interventions target symptom management, complication prevention, and patient education. Interventions should be individualized to the underlying cause of jaundice and the patient’s specific needs.

Promote skin integrity and comfort.
Apply fragrance-free moisturizers or emollients after bathing to hydrate dry skin and reduce itching. Encourage use of soft, loose-fitting cotton clothing to minimize friction and irritation. Keep fingernails trimmed short and smooth. Provide cotton gloves at night if scratching is severe.

Rationale: Pruritus from bile salt deposits causes intense itching that leads to scratching and skin breakdown. Moisturizers create a protective barrier, while mechanical strategies prevent trauma.

Administer antipruritic medications as prescribed.
Give antihistamines (diphenhydramine), bile acid sequestrants (cholestyramine), or specific agents like rifampin or naltrexone for cholestatic itch. Administer at bedtime when pruritus is often most severe.

Rationale: Cholestyramine binds bile salts in the intestine, reducing circulating levels and pruritus. Antihistamines provide sedation, which can improve sleep despite discomfort.

Maintain adequate nutrition and hydration.
Collaborate with a registered dietitian to develop a meal plan appropriate for liver function status. Offer small, frequent meals (5–6 times daily) rather than three large meals. Encourage high-calorie, high-protein foods if not contraindicated by hepatic encephalopathy (restrict protein if ammonia is elevated). Provide oral nutritional supplements. Monitor daily weights and intake/output.

Rationale: Anorexia, nausea, and early satiety are common in jaundice. Small, frequent meals are better tolerated and help maintain nutritional status. Protein restriction may be needed in encephalopathy to reduce ammonia production.

Provide oral care before meals.
Encourage tooth brushing, mouthwash, or oral swabs before eating to improve taste and stimulate appetite.

Rationale: Liver disease and jaundice often alter taste perception. Good oral hygiene removes unpleasant tastes and can increase food intake.

Administer prescribed medications safely.
Give antibiotics for cholangitis or hepatitis, antivirals for viral hepatitis, ursodeoxycholic acid for cholestatic conditions, lactulose for hepatic encephalopathy, or vitamin K for coagulopathy. Monitor for therapeutic effects and adverse reactions. Avoid hepatotoxic medications.

Rationale: Targeted pharmacologic therapy treats underlying causes and prevents complications. Many medications are metabolized by the liver, requiring dose adjustments or avoidance in hepatic impairment.

Implement infection control precautions.
Use standard precautions for all patient contact. If viral hepatitis is confirmed, implement appropriate transmission-based precautions (contact precautions for hepatitis A). Educate patients and families about hand hygiene and proper handling of body fluids.

Rationale: Some causes of jaundice (hepatitis A, hepatitis B) are contagious. Proper precautions prevent transmission to healthcare workers, family, and other patients.

Monitor for complications continuously.
Assess for signs of hepatic encephalopathy (confusion, asterixis, altered consciousness), gastrointestinal bleeding (hematemesis, melena, hemoccult-positive stools), spontaneous bacterial peritonitis (abdominal pain, fever, altered mental status in a patient with ascites), or acute kidney injury (decreased urine output, elevated creatinine).

Rationale: Patients with severe liver disease are at high risk for life-threatening complications requiring immediate intervention. Early recognition and prompt treatment improve outcomes.

Position for comfort and facilitate rest.
Elevate the head of the bed 30–45 degrees to ease breathing if ascites is present. Provide a quiet, dimly lit environment for rest. Cluster nursing care to allow uninterrupted sleep periods.

Rationale: Patients with liver disease and jaundice often experience profound fatigue. Rest supports healing and liver regeneration.

Coordinate phototherapy for neonatal jaundice.
Position the neonate under phototherapy lights with maximum skin exposure (diaper only). Protect eyes with opaque shields. Monitor skin temperature and hydration status. Encourage frequent breastfeeding or formula feeding (8–12 times per day) to promote bilirubin excretion through stool and urine.

Rationale: Phototherapy converts unconjugated bilirubin in the skin to water-soluble isomers that can be excreted without liver conjugation, effectively lowering bilirubin levels and preventing kernicterus.

Nursing Care Plan Examples

The following five nursing care plans illustrate comprehensive, patient-centered care for individuals with jaundice across different clinical scenarios. Each plan includes NANDA-approved nursing diagnoses, specific interventions with evidence-based rationales, and measurable expected outcomes.

---

Nursing Care Plan #1: Impaired Skin Integrity Related to Cholestatic Jaundice

Patient Scenario: A 58-year-old male with primary biliary cholangitis presents with severe jaundice and intractable pruritus for two weeks. Skin examination reveals multiple excoriations on arms, legs, and trunk from scratching. Patient reports pruritus rated 9/10, worse at night, significantly disrupting sleep.

Nursing Diagnosis: Impaired Skin Integrity related to pruritus secondary to elevated serum bile salts and bilirubin levels as evidenced by excoriations, scratch marks on extremities and trunk, and patient report of constant severe itching (9/10).

Related Factors:

• Accumulation of bile salts in skin tissue causes irritation
• Chronic scratching due to intense, unrelieved pruritus
• Dry skin associated with cholestatic jaundice
• Sleep deprivation from nighttime itching

Nursing Interventions and Rationales:

1. Assess skin integrity during every shift, focusing on areas most affected by scratching.
   Rationale: Systematic assessment allows early detection of skin breakdown, infection, or worsening excoriation, enabling prompt intervention before complications develop.
2. Apply thick, fragrance-free emollients or petroleum-based ointments to the entire body twice daily and after bathing.
   Rationale: Heavy moisturizers create an occlusive barrier that locks in hydration, reduces transepidermal water loss, and decreases itch intensity by up to 40% in cholestatic patients.
3. Administer cholestyramine 4 g PO three times daily before meals as prescribed.
   Rationale: Cholestyramine binds bile salts in the intestine, interrupting enterohepatic circulation and reducing circulating bile salt levels responsible for pruritus. Clinical response typically occurs within 1–2 weeks.
4. Encourage cool compresses, lukewarm baths with colloidal oatmeal, and avoidance of hot water.
   Rationale: Cool temperatures provide temporary vasoconstriction and nerve ending suppression that reduces itch sensation. Hot water dilates blood vessels and worsens itching by increasing histamine release.
5. Teach distraction techniques, including guided imagery, music therapy, and progressive muscle relaxation.
   Rationale: Cognitive-behavioral strategies redirect attention away from itch stimuli and activate descending pain inhibition pathways, reducing the scratch-itch cycle.
6. Provide soft cotton gloves for nighttime use and trim nails every 3–4 days.
   Rationale: Mechanical barriers prevent unconscious scratching during sleep, the period when pruritus intensity peaks. Short nails minimize skin trauma if scratching occurs.

Expected Outcomes:

• Patient will demonstrate healing of existing excoriations with no new skin breakdown within 5 days.
• Patient will report a pruritus intensity of ≤4/10 within 72 hours of initiating cholestyramine therapy.
• Patient will verbalize and demonstrate at least two non-pharmacologic itch relief techniques within 24 hours.
• Patient will achieve at least 6 hours of uninterrupted sleep per night within one week.

---

Nursing Care Plan #2: Imbalanced Nutrition Less Than Body Requirements

Patient Scenario: A 45-year-old female with alcoholic hepatitis and jaundice reports 15-pound unintentional weight loss over the past month. She has persistent nausea, states “food tastes like metal,” and typically eats less than 50% of meals. Current BMI 18.2, serum albumin 2.6 g/dL.

Nursing Diagnosis: Imbalanced Nutrition: Less than Body Requirements related to anorexia, nausea, and altered metabolism secondary to hepatic dysfunction as evidenced by 15-pound weight loss, BMI 18.2, serum albumin 2.6 g/dL, and intake of <50% of meals.

Related Factors:

• Persistent nausea and altered taste perception from liver dysfunction
• Early satiety due to hepatomegaly and ascites
• Increased metabolic demands from inflammation
• Zinc and vitamin deficiencies affecting taste

Nursing Interventions and Rationales:

1. Conduct a comprehensive nutritional assessment, including 24-hour dietary recall, weight trends, anthropometric measurements, and laboratory markers (albumin, prealbumin, transferrin).
   Rationale: Baseline data establishes the severity of malnutrition and guides intervention intensity. Albumin <3.5 g/dL and prealbumin <20 mg/dL indicate significant protein-calorie malnutrition requiring aggressive nutrition support.
2. Collaborate with a registered dietitian to develop an individualized meal plan providing 1.2–1.5 g protein/kg/day and 35–40 kcal/kg/day, unless protein restriction is needed for encephalopathy.
   Rationale: Patients with liver disease have increased protein and calorie needs to support hepatocyte regeneration and prevent muscle wasting. However, advanced cirrhosis with encephalopathy may require temporary protein restriction to 0.6–0.8 g/kg/day.
3. Offer five to six small, nutrient-dense meals and snacks throughout the day rather than three large meals. Provide the largest meal at breakfast when appetite is often best.
   Rationale: Small, frequent feedings reduce early satiety caused by hepatomegaly pressing on the stomach, improve total daily intake, and help maintain stable blood glucose in patients with impaired glycogen storage.
4. Administer ondansetron 4 mg IV/PO 30 minutes before meals as prescribed.
   Rationale: Antiemetic therapy controls nausea, allowing improved oral intake. Ondansetron is preferred in liver disease because it’s well-tolerated and doesn’t cause extrapyramidal side effects common with metoclopramide.
5. Provide zinc sulfate 220 mg daily and multivitamin supplementation as ordered.
   Rationale: Zinc deficiency is common in liver disease and contributes to dysgeusia (altered taste) and anorexia. Supplementation can restore taste perception and improve appetite within 2–3 weeks.
6. Encourage foods the patient prefers and make meals visually appealing. Allow family to bring favorite home-cooked foods if diet allows.
   Rationale: Patient preferences and familiar foods increase the likelihood of consumption. Cultural and personal food preferences significantly impact meal acceptance in hospitalized patients.

Expected Outcomes:

• Patient will demonstrate weight stabilization (no further loss) within 5 days and weight gain of 1–2 pounds per week thereafter.
• Patient will consume at least 75% of meals and meet daily caloric goals within 3 days.
• Patient will report improved appetite and decreased nausea rated ≤3/10 within 48 hours.
• Serum albumin will increase to ≥3.0 g/dL within 2–3 weeks with continued nutritional support.

---

Nursing Care Plan #3: Deficient Knowledge

Patient Scenario: A 62-year-old patient newly diagnosed with choledocholithiasis and obstructive jaundice scheduled for ERCP tomorrow. Patient asks, “Why am I yellow? Will this go away? What’s happening to me?” and appears anxious about the procedure.

Nursing Diagnosis: Deficient Knowledge related to unfamiliarity with disease process, treatment, and self-care requirements as evidenced by verbalized questions, misconceptions about condition, and expressed anxiety about upcoming procedure.

Related Factors:

• New diagnosis with complex pathophysiology
• Unfamiliarity with medical terminology and procedures
• Information overload in the acute care setting
• Anxiety is interfering with information retention

Nursing Interventions and Rationales:

1. Assess current understanding of jaundice, its cause, and treatment plan using the teach-back method.
   Rationale: Identifying existing knowledge, misconceptions, and learning gaps enables targeted, efficient teaching. Teach-back reveals what the patient actually understands versus what we assume they understand.
2. Provide clear, simple explanations using layperson language: “The yellow color comes from a bile pigment called bilirubin. A gallstone is blocking the tube that drains bile from your liver, causing bilirubin to back up into your blood.”
   Rationale: Health literacy varies widely. Avoiding medical jargon and using concrete, relatable language improves comprehension and retention, especially in patients with an education below high school level.
3. Use visual aids, including anatomical diagrams showing the liver, gallbladder, bile ducts, and the location of obstruction.
   Rationale: Visual learning tools enhance understanding of spatial relationships and disease processes. Studies show 65% of people are visual learners, and diagrams significantly improve comprehension of complex anatomy.
4. Explain the ERCP procedure, preparation, expected sensations, and post-procedure care in detail. Address specific questions and concerns.
   Rationale: Procedural teaching reduces anxiety, improves cooperation, and prepares patients for realistic expectations. Informed patients experience less pre-procedure anxiety and better post-procedure outcomes.
5. Teach signs and symptoms requiring immediate medical attention: worsening abdominal pain, high fever (>101°F), vomiting, confusion, or increased jaundice.
   Rationale: Educating patients about red flags enables early identification of complications such as pancreatitis post-ERCP, cholangitis, or biliary perforation, prompting timely care-seeking behavior.
6. Provide written educational materials at an appropriate literacy level (5th–8th grade) and reputable website resources for home reference.
   Rationale: Written materials reinforce verbal teaching and allow patients to review information at their own pace. Only 12% of U.S. adults have proficient health literacy, making readability critical.

Expected Outcomes:

• Patient will verbalize an accurate understanding of why jaundice occurred and how ERCP will relieve the obstruction within 2 hours of teaching.
• Patient will demonstrate correct understanding by explaining the condition and treatment in their own words (teach-back) before the procedure.
• Patient will state at least three signs/symptoms requiring immediate medical attention post-discharge.
• Patient will verbalize decreased anxiety about the procedure, reporting anxiety level ≤4/10.

---

Nursing Care Plan #4: Risk for Impaired Liver Function

Patient Scenario: A 50-year-old admitted with acute alcoholic hepatitis, jaundice, ascites, and elevated liver enzymes (ALT 320 U/L, AST 280 U/L, bilirubin 12.5 mg/dL). Patient has 25-year history of heavy alcohol use and expressed difficulty with abstinence in the past.

Nursing Diagnosis: Risk for Impaired Liver Function related to continued alcohol exposure, hepatotoxic substance use, and progression of underlying hepatic disease as evidenced by elevated liver enzymes, hyperbilirubinemia, and history of alcohol dependence.

Related Factors:

• Active alcohol use disorder with poor abstinence history
• Existing hepatocellular injury (alcoholic hepatitis)
• Potential exposure to additional hepatotoxins
• Malnutrition is compounding liver stress

Nursing Interventions and Rationales:

1. Monitor liver function tests (AST, ALT, alkaline phosphatase, total and direct bilirubin, albumin, PT/INR) every 24–48 hours and report significant changes or trends to the provider immediately.
   Rationale: Serial laboratory monitoring detects worsening hepatic function early. Rising bilirubin, prolonged INR, and dropping albumin indicate progressive liver failure requiring escalation of care.
2. Assess for early signs of hepatic encephalopathy every 4–8 hours: subtle personality changes, sleep pattern reversal, mild confusion, asterixis, or difficulty with simple math.
   Rationale: Hepatic encephalopathy can progress rapidly from subtle signs (grade I) to coma (grade IV). Early detection allows immediate initiation of lactulose and rifaximin to reduce ammonia levels before severe neurologic compromise occurs.
3. Administer medications cautiously, verifying hepatic dosing adjustments and avoiding hepatotoxic agents (acetaminophen, NSAIDs, certain antibiotics). Question orders for potentially harmful drugs.
   Rationale: The liver metabolizes most medications. Hepatic impairment prolongs drug half-lives, increasing toxicity risk. Acetaminophen doses >2 g/day can cause acute liver failure in patients with existing liver disease.
4. Provide addiction counseling and resources, including social work consultation, Alcoholics Anonymous information, and outpatient treatment programs. Use motivational interviewing techniques.
   Rationale: Continued alcohol use dramatically worsens prognosis and accelerates progression to cirrhosis and end-stage liver disease. Compassionate, non-judgmental counseling improves engagement with substance abuse treatment. Motivational interviewing is more effective than confrontational approaches.
5. Educate the patient about strict alcohol abstinence, avoidance of over-the-counter medications without provider approval, and liver-supportive nutrition.
   Rationale: Patient education empowers self-management and promotes behavior change. Abstinence is the single most important factor in halting disease progression. Many OTC products (acetaminophen, herbal supplements) are hepatotoxic.
6. Collaborate with a dietitian to ensure adequate caloric intake (30–35 kcal/kg/day) and moderate protein intake (1.0–1.5 g/kg/day unless encephalopathy is present).
   Rationale: Adequate nutrition supports hepatocyte regeneration and immune function. Protein is essential for liver repair, but must be restricted temporarily if ammonia levels rise causing encephalopathy.

Expected Outcomes:

• Patient will demonstrate stable or improving liver function tests within 5–7 days of admission with supportive care.
• Patient will remain free from hepatic encephalopathy, maintaining full orientation and no asterixis throughout hospitalization.
• Patient will verbalize commitment to alcohol abstinence and accept referral to addiction treatment services before discharge.
• Patient will correctly identify hepatotoxic substances to avoid (alcohol, acetaminophen, certain supplements) by discharge.

---

Nursing Care Plan #5: Anxiety Related to Uncertain Prognosis

Patient Scenario: A 38-year-old female recently diagnosed with a pancreatic head mass causing obstructive jaundice, scheduled for staging workup and possible Whipple procedure. She is tearful, restless, states “I’m terrified—is this cancer? Am I going to die?” and reports difficulty sleeping.

Nursing Diagnosis: Anxiety related to uncertain diagnosis, fear of cancer, and potential for life-altering surgery as evidenced by verbalized fears about mortality, tearfulness, restlessness, and insomnia.

Related Factors:

• Threat to health status and uncertain prognosis
• Fear of cancer diagnosis and death
• Anticipation of major surgery with significant complications
• Lack of control over the situation

Nursing Interventions and Rationales:

1. Conduct anxiety assessment using a standardized tool (GAD-7 or visual analog scale). Encourage the patient to verbalize specific fears and concerns in a private, unhurried setting.
   Rationale: Quantifying anxiety severity guides intervention selection and provides a baseline for measuring improvement. Allowing patients to name their fears reduces psychological burden and helps them feel heard and validated.
2. Provide honest, realistic information about the diagnostic process, emphasizing that many pancreatic masses are benign or treatable. Clarify that staging must occur before determining prognosis.
   Rationale: Uncertainty often increases anxiety more than known bad news. Accurate information corrects catastrophic thinking patterns and reduces anxiety rooted in misinformation. However, false reassurance should be avoided.
3. Teach and practice deep breathing exercises, progressive muscle relaxation, and guided imagery. Provide written instructions and encourage use whenever anxiety escalates.
   Rationale: Relaxation techniques activate the parasympathetic nervous system, physiologically countering the sympathetic “fight-or-flight” response. These evidence-based interventions reduce cortisol, slow heart rate, and decrease perceived anxiety within 10–15 minutes.
4. Offer anti-anxiety medication (lorazepam 0.5–1 mg PO PRN) as prescribed for severe anxiety episodes, especially before procedures or at bedtime.
   Rationale: Benzodiazepines provide rapid relief for acute anxiety that interferes with sleep or daily functioning. Short-term use is appropriate during diagnostic workup; however, non-pharmacologic strategies should be emphasized for long-term management.
5. Facilitate connection with hospital chaplain, social worker, or psychology/psychiatry services based on patient preference and need.
   Rationale: Interdisciplinary support addresses spiritual, emotional, and psychological distress beyond the nursing scope. Chaplains provide spiritual comfort, while mental health professionals offer cognitive-behavioral therapy and coping skill development.
6. Encourage the presence of supportive family members or friends during consultations and decision-making. Facilitate communication with the surgical and oncology teams.
   Rationale: Social support significantly reduces anxiety and improves coping. Having a trusted person present during complex medical discussions improves information retention and provides emotional security.

Expected Outcomes:

• Patient will report decreased anxiety from the initial level of 8/10 to ≤4/10 within 48 hours.
• Patient will demonstrate effective use of at least two relaxation techniques (deep breathing, guided imagery) within 24 hours of teaching.
• Patient will verbalize a realistic understanding of the diagnostic process and achievable short-term goals by the end of the shift.
• Patient will achieve at least 5–6 hours of sleep per night as reported within 3 days.

---

Frequently Asked Questions (FAQs)

Is jaundice a NANDA nursing diagnosis?

No, jaundice itself is not a NANDA-approved nursing diagnosis. Jaundice is a clinical sign (symptom) indicating elevated bilirubin levels. However, NANDA recognizes Neonatal Hyperbilirubinemia and Risk for Neonatal Hyperbilirubinemia as official nursing diagnoses for newborns.

For adult patients with jaundice, nurses use related NANDA diagnoses such as:

• Impaired Liver Function
• Risk for Impaired Liver Function
• Impaired Skin Integrity (related to pruritus)
• Imbalanced Nutrition: Less than Body Requirements
• Deficient Knowledge
• Anxiety

These diagnoses address the underlying conditions causing jaundice and the patient’s problems that result from elevated bilirubin.

What is an example of a nursing diagnosis for a patient with jaundice?

Common nursing diagnoses for patients with jaundice include:

Impaired Skin Integrity related to pruritus secondary to elevated bile salts, as evidenced by excoriations and patient report of severe itching.

Imbalanced Nutrition: Less than Body Requirements related to anorexia and nausea secondary to liver dysfunction as evidenced by 10-pound weight loss and decreased oral intake.

Risk for Impaired Liver Function related to hepatotoxic medication use or alcohol abuse.

Deficient Knowledge related to unfamiliarity with the disease process, as evidenced by questions and verbalized misconceptions about jaundice management.

The specific diagnosis depends on the individual patient’s presenting problems, underlying cause of jaundice, and priority nursing concerns.

What is the priority nursing diagnosis for a patient with severe jaundice and hepatic encephalopathy?

The priority nursing diagnosis for a patient with jaundice and signs of hepatic encephalopathy is Risk for Injury or Acute Confusion related to altered mental status secondary to elevated ammonia levels and hepatic dysfunction.

Hepatic encephalopathy represents a life-threatening complication where accumulated neurotoxins (primarily ammonia) impair brain function. Priority nursing interventions include:

• Continuous neurological monitoring and safety measures (bed alarm, fall precautions)
• Administering lactulose to reduce ammonia absorption
• Monitoring ammonia levels and liver function tests
• Maintaining a safe environment
• Protecting the airway if consciousness is significantly impaired

This takes precedence over other concerns like nutrition or skin integrity because neurologic deterioration can rapidly progress to coma and death if untreated.

How do you explain jaundice to a patient or new parent?

When explaining jaundice to patients or parents, use simple, non-medical language:

For parents of jaundiced newborns:
“Your baby’s skin and eyes look yellow because of a substance called bilirubin, which is normal in all babies. Bilirubin comes from the natural breakdown of red blood cells. Your baby’s liver is still learning how to process and remove bilirubin, so it builds up temporarily in the blood. This is very common and usually goes away on its own within 1–2 weeks.

We’re watching the levels carefully, and if they get too high, we’ll use special blue lights (phototherapy) that help break down the bilirubin so your baby can get rid of it more easily. Frequent feeding—at least 8–12 times per day—also helps because bilirubin leaves the body through poop and pee.”

For adult patients:
“The yellow color in your skin and eyes is called jaundice. It happens because a yellow pigment called bilirubin is building up in your blood instead of being filtered out by your liver. Think of bilirubin as waste that your body normally removes, like taking out the trash.

When your liver isn’t working properly [or when a gallstone is blocking the drain], bilirubin can’t leave your body, so it shows up in your skin and eyes. We’re working to find and treat what’s causing this problem so your liver can work normally again.”

Which nursing assessment finding requires immediate intervention in a jaundiced patient?

Several assessment findings in jaundiced patients constitute emergencies requiring immediate intervention:

Altered mental status or confusion: May indicate hepatic encephalopathy (ammonia toxicity affecting the brain), requiring immediate lactulose administration, ammonia level testing, and possible ICU transfer.

High fever (>101°F) with right upper quadrant pain: Suggests acute cholangitis (infected bile ducts), a life-threatening condition requiring urgent IV antibiotics and possible emergency biliary drainage.

Signs of gastrointestinal bleeding: Hematemesis (vomiting blood), melena (black tarry stools), or hemoccult-positive stools indicate variceal bleeding or gastric ulcers, common in liver disease, requiring immediate resuscitation and endoscopy.

In neonates—lethargy, poor feeding, high-pitched cry, or arching: These are warning signs of acute bilirubin encephalopathy (kernicterus), requiring immediate bilirubin level check and possible exchange transfusion to prevent permanent brain damage.

Any of these findings requires immediate physician notification and rapid intervention to prevent mortality or permanent neurologic injury.

References

1. American Liver Foundation. (2021). Jaundice. Retrieved from https://liverfoundation.org/for-patients/about-the-liver/diseases-of-the-liver/jaundice/
2. Fargo, M. V., Grogan, S. P., & Saguil, A. (2017). Evaluation of Jaundice in Adults. American Family Physician, 95(3), 164-168.
3. Gulanick, M., & Myers, J. L. (2017). Nursing Care Plans: Diagnoses, Interventions, and Outcomes (9th ed.). Elsevier.
4. Herdman, T. H., & Kamitsuru, S. (Eds.). (2018). NANDA International Nursing Diagnoses: Definitions and Classification 2018-2020 (11th ed.). Thieme.
5. National Institute of Diabetes and Digestive and Kidney Diseases. (2020). Jaundice. Retrieved from https://www.niddk.nih.gov/health-information/liver-disease/jaundice
6. Roy-Chowdhury, N., & Roy-Chowdhury, J. (2021). Classification and causes of jaundice or asymptomatic hyperbilirubinemia. In T. W. Post (Ed.), UpToDate. Waltham, MA: UpToDate Inc.
7. Toney-Butler, T. J., & Thayer, W. M. (2021). Nursing Process. In StatPearls. Treasure Island (FL): StatPearls Publishing.
8. World Health Organization. (2021). Jaundice. In International Classification of Diseases, 11th Revision (ICD-11). Retrieved from https://icd.who.int/browse11/l-m/en#/http://id.who.int/icd/entity/1744576348